A new EU-funded project to boost the capacity and efficiency of the next generation of optical networks has just got underway. The PHASORS ('Phase sensitive amplifier systems and optical regenerators and their applications') initiative is funded under the 'Information and communication technology' (ICT) Theme of the Seventh Framework Programme (FP7) to the tune of EUR 3.9 million.
SOLX, Inc. announced today U.S. Food and Drug (FDA) 510(k) clearance for the SOLX 790 to perform Titanium:Sapphire laser trabeculoplasty (TLT). The 510(k) clearance was based on the results of a multi-center, international clinical trial that established equivalency of TLT to ALT in the ability to reduce intraocular pressure (IOP) in patients having primary open angle glaucoma and poorly controlled IOP on maximally tolerated medications and/or prior failed trabeculoplasty. The laser had previously been approved for sale in Europe and Canada.
Magnetic resonance scans will be safer for children and other patients needing anaesthesia, thanks to new kinds of optical sensors developed by a team of European researchers.
Alcon, Inc. announced the international release of the new AcrySof® Phakic Lens at the 2008 European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting in Berlin, Germany. Based on Alcon's proven and trusted AcrySof® intraocular lens (IOL) material, Alcon designed the AcrySof® Phakic Lens to become the surgeon's preferred solution for patients with moderate to high levels of myopia (nearsightedness).
PathoLase, Inc., an emerging leader in the medical technology industry, reported today that a select group of leading podiatrists in several markets in the US are now treating patients who suffer from toenail fungus (Onychomycosis) with its ground breaking laser technology. Using PathoLase's patented PinPointe FootLaser system, podiatrists in Sacramento, San Jose, Salt Lake City and Belleville, New Jersey are open for business treating their patients' toenail fungus.
A bizarre but well-established aspect of quantum physics could open up a new era of electronic detectors and imaging systems that would be far more efficient than any now in existence, according to new insights by an MIT leader in the field.
Greenlight Initiative, a New York City based LED-lighting sales organization and solutions provider, today announced its plans to implement full third party photometric testing and qualification for all of its product lines beginning January 2009. This program, intended to independently verify and extend upon any available manufacturers' test data, is in addition to Greenlight's previously announced qualitative evaluation program.
Daylight Solutions, Inc., a manufacturer of advanced molecular detection and imaging solutions, today announced that it has established a new world record for a broadly tunable solid state mid-infrared laser source in a commercial product. The company integrated a Quantum Cascade semiconductor gain chip from ALPES lasers (Switzerland) into its own patented tunable external-cavity laser (EC-QCL) system. The result was a single frequency source that tuned across 275 wavenumbers, or 24% of the laser's center wavelength at 8.8µm.
Killer dyes that can wipe out bacteria could help solve the superbug problems faced by surgical patients, scientists heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.
Syntec Optics, the largest independent manufacturer of custom plastic optics in North America, has been granted a US patent for its HRDT(TM) (High Refraction Diamond Turning) technology, in production use since late 2005. Most Syntec HRDT projects have been defense-related. However, HRDT holds promise for other markets, such as datacom, that require asymmetric, low-cost optics with high wave sensitivity and strong heat resistance, and share with defense an imperative to shave development cycles.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.